Where to Buy Semaglutide: 7 Purity & Identity Checks

Semaglutide exists in 3 parallel markets—FDA-approved brands (Ozempic/Wegovy at $1,300–1,500/month), compounded formulations (under increasing FDA scrutiny), and research-grade peptide (RUO, $80–200 for 5–10 mg)—making it the most complex peptide to buy correctly in 2026. Counterfeit semaglutide was flagged by both INTERPOL and Europol in 2025. Novo Nordisk patent enforcement has caused multiple vendors to delist. Salt form confusion (free base vs sodium vs acetate) adds a verification layer that does not exist for simpler peptides.

This article applies 7 verification checks to semaglutide specifically, using data from Peptigrity’s independent lab tests, community reviews, and reviewed peptide shops. Peptigrity does not sell peptides or recommend vendors—the platform provides the analytical data for informed decisions.

What Is Semaglutide and Why Is the Buying Landscape So Complex?

Semaglutide is a GLP-1 receptor agonist—a 31-amino-acid peptide with 94% structural homology to native human GLP-1, modified with a C18 fatty diacid side chain that enables albumin binding and extends the half-life to approximately 7 days. Molecular weight: ~4,113.6 Da. CAS: 910463-68-2.

The clinical evidence for semaglutide is the strongest of any compound on Peptigrity’s platform. The STEP 1 trial (n=1,961) demonstrated 14.9% average body weight reduction at 68 weeks versus 2.4% for placebo. The SELECT cardiovascular outcomes trial (n=17,604) demonstrated a 20% reduction in major adverse cardiovascular events. These are FDA-approved indications supported by Phase 3 RCT data—unlike most research peptides on the platform.

3 markets coexist for the same molecule:

1. 
   FDA-approved brands: Ozempic (type 2 diabetes) and Wegovy (weight management) manufactured by Novo Nordisk under cGMP. $1,300–1,500/month without insurance.

2. 
   Compounded semaglutide: prepared by 503A/503B pharmacies with physician prescription. $200–600/month. Under increasing FDA pressure since the shortage designation was lifted in 2024. Some compounders shifted to sodium or acetate salt forms.

3. 
   Research-grade semaglutide (RUO): lyophilised powder from grey-market vendors. $80–200 for 5–10 mg. No mandatory quality standards. This is the market Peptigrity monitors.

Europol’s Operation SHIELD VI (April–November 2025) specifically highlighted counterfeit semaglutide-based products as an emerging threat, seizing €33 million across 30 countries. The buying landscape is more complex for semaglutide than for any other research peptide.

Semaglutide-Specific Risks That Don’t Apply to Other Peptides

Semaglutide carries 4 buying risks that do not apply to most other research peptides: lipidation-driven oxidation sensitivity, salt form confusion, counterfeit branded products, and vendor delisting under patent pressure.

• 
  C18 lipidation and oxidation. Semaglutide’s fatty diacid modification increases solid-state oxidation susceptibility even when lyophilised. Scientifically, cold shipping is more justified for semaglutide than for non-lipidated peptides such as BPC-157 or ipamorelin. In practice, most RUO vendors ship at ambient temperature regardless. The practical takeaway: store at −20°C immediately on arrival—prompt freezer storage matters more for semaglutide than for simpler peptides.

• 
  Salt form confusion. Semaglutide free base (Novo Nordisk’s approved formulation) is not identical to semaglutide sodium or semaglutide acetate. The FDA has flagged these salt forms as potentially different compounds. Mass spectrometry can differentiate—but only if you know to check. Ask the vendor: is this semaglutide free base, sodium, or acetate?

• 
  Counterfeit branded products. Counterfeit Ozempic pens and Wegovy injectors circulate globally. INTERPOL’s Operation Pangea XVII (December 2024–May 2025) seized 50.4 million doses of illicit pharmaceuticals. This primarily affects pre-filled pen products—not lyophilised research-grade vials—but any vendor claiming “pharmaceutical-grade” semaglutide at research prices is suspect.

• 
  Vendor delisting. Novo Nordisk patent enforcement has caused multiple US vendors to remove semaglutide from their catalogues. Availability changes rapidly—a vendor stocking semaglutide last month may not today. Verify current availability on the vendor’s website before ordering.

7 Things to Check Before Ordering Semaglutide

The same 7-check verification framework that applies to all research peptides applies to semaglutide—with additional attention to salt form, lipidation-related oxidation, and pricing anomalies specific to GLP-1 compounds.

1. Third-Party HPLC Purity (≥98%)

Check whether the vendor publishes a Certificate of Analysis from a named third-party lab—not in-house testing. HPLC purity ≥98% is the research-grade standard. Cross-reference on peptigrity.com/lab-tests—filter by “semaglutide” to see community-submitted purity data across multiple vendors. The study “Peptide Impurities in Commercial Synthetic Peptides” (PMC2238048) demonstrated that contamination at 1% of total peptide weight produced measurable biological effects.

2. Mass Spectrometry Identity (~4,113.6 Da) and Salt Form

HPLC measures purity but not identity. Mass spectrometry confirms the vial contains semaglutide (expected MW ~4,113.6 Da for free base). MS also differentiates between salt forms—sodium and acetate salts produce different observed masses. If the vendor’s CoA includes HPLC but no mass spectrometry, both identity and salt form are unverified. For the full MS methodology, see Mass Spectrometry for Peptides: Verifying Identity & Molecular Weight.

3. CoA From a Named, Verifiable Lab

The CoA should name a specific testing laboratory listed on Peptigrity’s testing labs directory—Janoshik, Chromate, Freedom Diagnostics, or another lab with a verification portal. For semaglutide specifically, check that the CoA specifies which salt form was tested. See Red Flags in Peptide Certificates of Analysis for the full 12-point fraud detection checklist.

4. Independent Data on Peptigrity

Search peptigrity.com/lab-tests for the vendor name + semaglutide. Check the shop’s profile on peptigrity.com/shops—trust score (0–5), ✓ Lab Verified badge, and number of community-submitted lab tests. Semaglutide is tagged on many top-rated shop profiles. Independent lab data submitted by the community carries more weight than vendor-published CoAs.

5. Community Reviews Mentioning Semaglutide

Read reviews on the vendor’s Peptigrity page. Each review includes 5 sub-ratings: Quality, Delivery, Pricing, Customer Service, and Product Accuracy. GLP-1 buyers are among the most active reviewers on the platform. Look for semaglutide-specific mentions of reconstitution clarity, product accuracy, and packaging quality.

6. Vial Presentation and Storage

Lyophilised semaglutide should be a white to off-white powder. Discolouration (yellow or brown) indicates oxidation of the C18 fatty acid chain—a semaglutide-specific degradation pathway. In practice, most RUO vendors ship semaglutide at ambient temperature in standard tracked parcels, the same as any other lyophilised peptide. Cold shipping with ice packs is rare among grey-market sellers. For a 2–5 day domestic transit of sealed lyophilised powder, ambient shipping is acceptable—but store at −20°C immediately on arrival. Semaglutide’s lipidation makes prompt freezer storage more important than for non-lipidated compounds. After reconstitution: 2–8°C, use within 28 days.

7. Pricing Reality Check

Research-grade semaglutide pricing (March 2026):

• 
  5 mg vial: $40–100.

• 
  10 mg vial: $80–200.

• 
  Compounding pharmacy: $200–600/month with prescription.

• 
  FDA-approved brands: $1,300–1,500/month (Ozempic/Wegovy).

Below $40 for 10 mg is suspicious—semaglutide synthesis is more expensive than simpler peptides due to the C18 lipidation step. “Pharmaceutical-grade” at research prices ($50–100) is almost certainly not what it claims. Compare across vendors on Peptigrity. See Peptide Purity Standards: What Percentage Is Actually Acceptable? for the framework connecting price to quality.

Semaglutide on Peptigrity’s Lab Test Database

Semaglutide is one of the most frequently tested peptides on Peptigrity—filter by compound name at peptigrity.com/lab-tests to compare independent purity data across vendors before ordering.

The data is community-submitted from third-party laboratories—real products purchased by real buyers, not vendor marketing. Purity averages vary by vendor. Some consistently achieve 99%+; others produce results in the 95–97% range. This variance is precisely why independent verification matters.

Use the data before ordering. If a vendor has multiple semaglutide tests on Peptigrity averaging 99%+ from named labs, that is the strongest quality signal available. If a vendor has zero tests, quality is unverified. Browse the semaglutide peptide guide for the complete compound profile alongside lab data. Compare with tirzepatide—the dual GIP/GLP-1 agonist commonly evaluated alongside semaglutide.

Compounded vs Research-Grade Semaglutide: What’s the Difference?

Semaglutide is available through 3 quality tiers: FDA-approved brands (cGMP manufacturing, $1,300–1,500/month), compounded formulations (USP 795/797, $200–600/month with prescription), and research-grade peptide (no mandatory standards, $80–200, verified through Peptigrity).

The quality spectrum: FDA-approved > compounded > research-grade. The price spectrum inverts. Peptigrity exists to verify quality at the research-grade level—providing the analytical data that regulation does not require for RUO products.

Compounding pharmacy access is under pressure. The FDA lifted the semaglutide shortage designation in early 2024, narrowing the legal cover for compounders. Some pharmacies stopped; others shifted to sodium or acetate salt forms. The FDA’s Category 2 bulk drug substances list defines the current compounding framework. Check current compounding availability with a physician before assuming this pathway is accessible.

Frequently Asked Questions

What purity should research-grade semaglutide have?

≥98% HPLC from a third-party lab. ≥99% is premium. The C18 lipidation makes semaglutide more oxidation-susceptible than simpler peptides—purity degrades faster if stored incorrectly. Cross-reference on peptigrity.com/lab-tests.

How much does research-grade semaglutide cost?

$80–200 for 5–10 mg lyophilised vial. Below $40 for 10 mg is suspicious. Pricing changes frequently—compare across vendors on peptigrity.com/shops. Vendors delist under Novo Nordisk patent pressure, so check current availability before ordering.

Is research-grade semaglutide the same as Ozempic?

The active molecule is the same (semaglutide, 31 amino acids, MW ~4,113.6 Da). The quality is not. Ozempic is manufactured under cGMP with full FDA oversight, stability testing, and sterile fill. Research-grade semaglutide has no mandatory manufacturing standards—purity and identity must be verified independently. They are not interchangeable.

Why do some vendors no longer stock semaglutide?

Novo Nordisk patent enforcement has pressured US vendors to remove semaglutide. Eli Lilly has similarly pressured vendors carrying tirzepatide. Availability shifts rapidly. Check the vendor’s current website and their Peptigrity profile before assuming a product is available.

How should I store semaglutide after delivery?

Lyophilised: −20°C freezer immediately on arrival. Semaglutide’s C18 modification makes it more oxidation-sensitive than non-lipidated peptides. After reconstitution: 2–8°C refrigerator, use within 28 days. Never freeze reconstituted solution.

For the complete buyer verification framework, see How to Verify Peptide Quality Before You Buy and What to Look for in a Peptide Shop: A Buyer’s Checklist. Browse all peptide shops ranked by trust score.

This article is for educational and informational purposes only and does not constitute medical advice. Semaglutide is an FDA-approved drug for specific indications (Ozempic, Wegovy) and is also available as a research compound not approved for general human use. Research-grade semaglutide is not equivalent to pharmaceutical-grade products. Always consult a qualified healthcare provider before using any peptide or medication. Peptigrity is an independent review platform and does not sell, endorse, or recommend specific products or vendors.